Health Care/Hospital
This World Oral Health Day, Sensodyne introduces NEW Triple Action Formula: 'Sensitivity Gum & Enamel'
* Sensodyne has expanded its fastest growing Advanced range of Sensitivity and Gum with its latest innovation that helps relieve Sensitivity, restore Gum Health & strengthen Enamel. * All-year round NEW awareness campaign to educate consumers on the importance of dealing with Enamel erosion a...
FWD Group completes additional investment in Malaysia; becomes majority shareholder in FWD Takaful Berhad
KUALA LUMPUR, Malaysia, March 11, 2024 /PRNewswire/ -- FWD Group Holdings Limited ("FWD Group" or "FWD") today announced the completion of an additional investment for a further 21 percent stake in FWD Takaful Berhad ("FWD Takaful"). FWD is now the majority shareholder in FWD Takaful, with a 70...
RemeGen Presents Oral Presentation on Evaluation of Its Proprietary Disitamab Vedotin (RC48) for Cervical Cancer at ESGO 2024
YANTAI, China, March 11, 2024 /PRNewswire/ -- RemeGen Co. Ltd.
APPIS 2024: Healthcare Stakeholders Come Together to Prioritize Action for Better Patient Outcomes in Asia Pacific, Middle East, and Africa
* Since 2021, the APPIS platform has brought together over 2,000 people from more than 65 countries to address barriers to healthcare access. * Over 40 healthcare expert speakers will cover critical topics from health literacy, health policy shaping and future readiness at the APPIS Summit 202...
Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Macau
-- Macau is on course to become the first of Everest's Asian territories to get etrasimod approval -- Can provide access to patients in China's Greater Bay area and rest of Asia SHANGHAI, March 11, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceu...
Ascletis Announces Poster Presentation of Phase II Study Final Results of FASN Inhibitor ASC40 for Treatment of Acne at 2024 AAD Annual Meeting
HANGZHOU and SHAOXING, China, March 10, 2024 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces the poster presentation of Phase II study final results of ASC40, a first-in-class fatty acid synthase (FASN) inhibitor for treatment of acne, at the 2024 American Academy of...
Launch of CMDF Showcase Event to Share Achievements, Promote Chinese Medicine Culture to Public and Remark a New Mileage of Chinese Medicine Development
HONG KONG, March 9, 2024 /PRNewswire/ -- In 2019, the HKSAR Government officially launched the Chinese Medicine Development Fund (CMDF) to promote the development and elevate the overall standards of the Chinese medicine (CM) sector inHong Kong. Starting from today, the CMDF will host a four-day ...
Regor Initiates Phase 2 Study of Oral Once-daily GLP-1 Agonist RGT-075 for the Treatment of Obesity
CAMBRIDGE, Mass., March 8, 2024 /PRNewswire/ -- Regor Therapeutics Group ("Regor"), a clinical-stage global biopharmaceutical company powered by a cutting-edge drug discovery engine and differentiated clinical development pipeline, today announced that its Phase 2 trial of the highly selective or...
Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range
Highlights * Clarity recently reported that in its diagnostic Phase 1/2 trial, COBRA, 64 Cu-SAR-bisPSMA was found to be safe and highly effective in detecting prostate cancer (PC) lesions in patients with biochemical recurrence (BCR). * In trial participants where standard of care (SOC) imagin...
Mabwell to Present the Clinical Data of 9MW2821 in Cervical Cancer as Focused Plenary Oral Presentation at 2024 Society of Gynecologic Oncology Annual Meeting on Women's Cancer
SHANGHAI, March 8, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that it will present the clinical study results on the efficacy and safety of the novel Nectin-4-targeting ADC 9MW2821 for patients with recurrent or ...
Wellysis and Artella Solutions Launch Innovative Remote Cardiac Monitoring Service in the US.
SEOUL, South Korea, March 8, 2024 /PRNewswire/ -- Wellysis, a digital
healthcare company spun off from Samsung, has announced the launch of remote
cardiac monitoring service in the US in partnership with Artella Solutions
(ARTELLA).
TransThera Announced Global Phase 3 Clinical Trial for Cholangiocarcinoma Authorized in the European Union and Orphan Drug Designation for Tinengotinib to Treat Biliary Tract Cancer Granted by European Medicines Agency
NANJING, China and GAITHURSBURG, Md., March 8, 2024 /PRNewswire/ -- TransThera, a clinical-stage biopharmaceutical company dedicated to innovating differentiated drugs globally, today announced that the randomized, controlled, global multicenter Phase 3 trial (FIRST-308) of tinengotinib versus ph...
"AXA Women's Health Centre" officially unveils on International Women's Day
AXA and Chiron Medical join hands to introduce Hong Kong's first women-exclusive health centre Comprehensive care for women's health with an entire female medical team at the helm HONG KONG, March 8, 2024 /PRNewswire/ -- Commemorating International Women's Day on 8 March, AXA Hong Kong andMacau ...
Launching Bneuron - A Breakthrough Dairy Supplement For Brain Protection
SEOUL, South Korea, March 8, 2024 /PRNewswire/ -- Bneuron milk, a breakthrough product in the health and wellness industry, has been enteringSouth Korea diary market. The product is scientifically proven to offer multiple benefits for the brain and nervous system. By delivering essential nutrient...
Advancing Healthcare Access: Genesis MedTech Teams Up with Silk Road Medical to Serve Patients affected by Carotid Artery Disease in China
WUXI, China, March 7, 2024 /PRNewswire/ -- Silk Road Medical (NASDAQ: SILK), a medical device company based inCalifornia USA and Genesis MedTech Group have signed an exclusive distribution agreement to introduce the TCAR® core products, ENROUTE® Transcarotid Neuroprotection System and ENROUTE® T...
VISEN Announces Acceptance of a Biologics License Application for Lonapegsomatropin in China
SHANGHAI, March 7, 2024 /PRNewswire/ -- VISEN Pharmaceuticals (VISEN), an innovative biopharmaceutical company focused on endocrine diseases, today announced that the Biologics License Application (BLA) for Lonapegsomatropin (TransCon hGH) was accepted by the China National Medical Products Admi...
Uniting for Women's Wellness on IWD - From China to Uzbekistan
- Interviewing Wang Leilei, the first blind model in China, and Viktoriya Tsay, head of Prenatal and Neonatal Medicine Department at Genscreen, BGI Genomics JV laboratory inUzbekistan. HONG KONG, March 8, 2024 /PRNewswire/ -- To mark International Women's Day (IWD), BGI Genomics interviewed Wang...
Pudu Robotics to Showcase Comprehensive Solutions at Australian Healthcare Week
SYDNEY, March 8, 2024 /PRNewswire/ -- Pudu Robotics ("PUDU"), the global leader in commercial service robots, is excited to announce its participation in the forthcoming Australian Healthcare Week (AHW), the biggest and most influential healthcare gathering in the southern hemisphere, scheduled f...
Chime Biologics Achieves ISO 27001 Certification to Strengthen Information Security in the CDMO Industry
WUHAN, China, March 7, 2024 /PRNewswire/ -- Chime Biologics, a leading global CDMO that enables its partners' success in biologics, today announced that it has obtained ISO/IEC 27001:2022 certification on information security management systems. After passing rigorous reviews on all the items of...
P2G Foundation is Leading the Charge in Empowering Singapore's Homeless Population
SINGAPORE, March 7, 2024 /PRNewswire/ -- P2G Foundation announces its commitment to empowering lives and fostering hope forSingapore's unhoused population. With an unshakable commitment to extending support and creating pathways to opportunity, P2G Foundation emerges as a guiding light of compas...
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25Animated Life in Yunnan
[Picked up by 281 media titles]
2024-04-18 14:00